clonidine has been researched along with Bone Loss, Osteoclastic in 1 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Limonard, EJ | 1 |
Schoenmaker, T | 1 |
de Vries, TJ | 1 |
Tanck, MW | 1 |
Heijboer, AC | 1 |
Endert, E | 1 |
Fliers, E | 1 |
Everts, V | 1 |
Bisschop, PH | 1 |
1 trial available for clonidine and Bone Loss, Osteoclastic
Article | Year |
---|---|
Clonidine increases bone resorption in humans.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Biomarkers; Bone Remodeling; Bone Resorption; Cell | 2016 |